logo
New Staples retail boss takes it ‘easy'

New Staples retail boss takes it ‘easy'

Boston Globe16 hours ago

In January, Warkentin became president of Staples' US retail operations. One of his first big moves as the top executive: launching a new campaign around the familiar fat red button, with billboards, store signs, and social media posts. (The button shows up as 'E.B.' on LinkedIn.) And yes, you can still buy buttons that say 'that was easy' for your office cubicle.
The Easy Button concept is in keeping with Staples founder
Tom Stemberg
's ethos around making life easier for customers, Warkentin says.
Advertisement
'It wasn't just a marketing campaign,' Warkentin said. 'It was a commitment.'
The idea takes on new resonance now that the company has pivoted to focus more on services and less on traditional brick-and-mortar retail, particularly as consumers and small businesses are using less paper, once the lifeblood of a Staples store.
In that regard, Warkentin cited several growth areas such as same-day sign printing, TSA Precheck enrollment, tech support, and 'iPostal' digital mailboxes. Warkentin said he doesn't expect to significantly add to the company's network of 900-plus stores in the United States, but he does want to optimize the stores Staples already has.
Advertisement
'What you hopefully are seeing is the evolution of a strategy playing out where we're moving more towards a service-based approach versus a product-based approach, which is where the whole 'Easy campaign' comes in,' Warkentin said. 'Leveraging something from the past and applying it to something that's new and more modern.'
For Mass. CEOs, competition is on the menu
The 'C' word seems to be everywhere you turn these days.
Case in point:
State Street
chief executive
Ron O'Hanley
and
Rapid7
chief executive
Corey Thomas
are hosting an unusual dinner meeting on Wednesday, and 'competitiveness' is on the menu. The meeting is unusual because O'Hanley and Thomas invited board chairs of local business associations as opposed to the associations' chief executives — other executives whose day jobs involve leading companies, not trade groups.
O'Hanley chairs the
Massachusetts Competitive Partnership
, and is the former chair of the
Greater Boston Chamber of Commerce
's board, a role he handed off to Thomas a year ago.
In their invite, they write that the challenges to the state's economic competitiveness have never been greater. They cite headwinds facing leading industries, and existential threats posed to universities and hospitals. They point to high construction and housing costs, as well as taxes. And they express concerns about roads and public transit.
Their stated goal: to identify actions that local business leaders can take to address 'what is now a critical situation.'
The meeting follows a
Pioneer Institute
report in April, citing Bureau of Labor Statistics data, showing that private sector employment in Massachusetts remains 0.74 percent lower than in January 2020 — the third-worst showing of any state. And on Thursday, the
Massachusetts Business Roundtable
released a report showing an increasing number of their members are hiring remote workers in other states to fill jobs.
Advertisement
'Massachusetts has more going for it than it has challenges,' said
Citizens Bank
executive
Lisa Murray
, who plans to attend as chair of the Roundtable. 'We need to make sure we're telling that story, so we're focusing on and highlighting all the amazing things that happen here. . . . But we can't be naive and stick our head in the sand, and not address the issues that are as clear as day.'
For Boston Arts Academy, a big check from big fans
When Mayor
Michelle Wu
Josh Boger
and
Amy Boger
to step up.
The couple has supported the visual and performing arts high school for several years, ever since they received an inquisitive visit by some academy students to their Summer Street studio. Josh Boger is a scientist by training, and a former chief executive of biotech powerhouse Vertex Pharmaceuticals, while his wife is
a retired pediatrician. But now he's much more focused on photography, particularly underwater, and she's more focused on ceramics.
Boger said it was a no-brainer for the couple to donate that final $1 million, to make the match sought by the anonymous donor and bring the total amount raised by the
Boston Arts Academy Foundation
to $35.9 million — wrapping up the campaign. The couple had donated to BAA before, he said, but this is their largest single gift to the school. They were recognized by Wu at a reception at the Parkman House on Friday. (The gift will go to a scholarship fund, to support BAA graduates in college,
named after foundation chief executive
Denella Clark
.)
Advertisement
He said he's impressed that admissions are not based on middle school grades, but instead on auditions and portfolios. He believes many students who are artistically inclined can go on to become great mathematicians and scientists; the pursuits of arts and of science are more similar than many people realize.
He probably gets as much out of the student visits as the kids do — if not more.
'It's the questions they ask, and I realize that they're seeing certain aspects [of my photography] for the first time,' Boger said. 'That makes me more interested in those aspects. . . . It reminds me to look at it more carefully.'
Wu sees mounting interest in office conversions
Interest continues to build in Mayor
Michelle Wu
's tax-
That's the message the mayor conveyed at an
Associated Industries of Massachusetts
meeting on Thursday, after AIM chief executive
Brooke Thomson
asked what her administration is doing to help address the region's housing shortage.
Wu touted her conversion program, which offers developers a 75-percent property tax break over 29 years. She noted projects totaling nearly 800 units are in the pipeline, soon to climb to around 1,000. The hope: bring more life to a downtown hurt by the rise of remote work, while creating more housing.
Advertisement
Actual construction, though,
Wu rattled off several other city housing initiatives, and she fielded a separate question from Thomson about buttressing the city's competitiveness. She indicated that perhaps the most important draw for businesses is 'making sure Boston is a city where employees, where people, want to build their lives.'
There was little indication of how some of Wu's more progressive policies — increased requirements for affordable housing, for example, or climate-friendly construction — faces some resistance in the business community. A number of prominent executives have donated to Josh Kraft, her challenger in the fall election.
To introduce Wu at the AIM event,
M&T Bank
regional president
Grace Lee
talked about how Wu stood her ground before confrontational members of Congress in March, over immigration policies.
Wu hearkened back to that moment when Thomson asked about the mayor's controversial rollout of more bike lanes, a rollout that Kraft targeted
'When I was sitting in that congressional hearing room in D.C.,' Wu recalled, 'and the questions were coming fast and furious and trying to, you know, call me names, and this and that, I quickly realized, . . . none of these congressional Republicans have been in a bike lane meeting in the city of Boston.'
Advertisement
Jon Chesto can be reached at

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Marea Therapeutics Appoints Shishir Gadam, Ph.D., as Chief Technical Officer
Marea Therapeutics Appoints Shishir Gadam, Ph.D., as Chief Technical Officer

Business Wire

timean hour ago

  • Business Wire

Marea Therapeutics Appoints Shishir Gadam, Ph.D., as Chief Technical Officer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced the appointment of Shishir Gadam, Ph.D., as chief technical officer. Dr. Gadam has extensive experience in the biotechnology industry and brings deep expertise and leadership in biologics development and manufacturing to Marea Therapeutics. Dr. Gadam was most recently chief technical officer at Cargo Therapeutics and responsible for technical operations for the cell therapy portfolio. Prior to Cargo, he held the position of vice president and head of cell therapy global manufacturing sciences & technology at Juno therapeutics, a Celgene company and Bristol Myers Squibb where he was instrumental in launch of two cell therapy commercial CAR-T products. During his tenure at Genetech/Roche from 2006-2018, he held positions of increasing responsibility across technical development and manufacturing advancing multiple biologics programs. Dr. Gadam started his career at Merck & Company in developing bioprocesses for vaccines. He holds a Ph.D. in Biochemical Engineering from Rensselaer Polytechnic Institute, a M.S. in Chemical Engineering from West Virginia University and a B.S. in Chemical Engineering from the Institue of Chemical Technology, Mumbai, India. 'We are delighted to welcome Shishir to our senior leadership team,' said Josh Lehrer, M.D., FACC, chief executive officer of Marea Therapeutics. 'Shishir brings a remarkable track record of technical leadership across biologics, vaccines, and cell therapies, and his deep expertise in CMC and manufacturing operations will be instrumental as we advance our pipeline toward late-stage development. His proven ability to scale innovative therapies and build world-class technical capabilities will be invaluable as we prepare for Phase 3 readiness and continue to grow Marea into a leading cardioendocrine company.' 'I'm thrilled to join Marea at such an exciting moment in its growth,' said Dr. Gadam. 'The company's commitment to advancing first-in-class therapies for cardioendocrine diseases is both scientifically compelling and deeply meaningful. I look forward to working alongside this exceptional team to build and scale robust technical operations that will accelerate development and ultimately deliver transformative medicines to patients.' About Marea Therapeutics Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. The company's lead therapy, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly. To learn more, please visit and follow us on LinkedIn and X.

Selecting The Right GenAI Tool For Sales Productivity
Selecting The Right GenAI Tool For Sales Productivity

Forbes

time2 hours ago

  • Forbes

Selecting The Right GenAI Tool For Sales Productivity

Mickey Singh is a senior leader at Versa Networks, renowned for his proven track record in commercializing emerging technologies. The rise of artificial intelligence has sparked a gold rush across industries, and sales productivity is no exception. As the Global Head of Sales Enablement, I'm constantly fielding calls, emails and LinkedIn messages about the latest AI tools promising to revolutionize sales. Sound familiar? From established sales tech giants to agile startups, everyone's touting AI. But amid the noise, one critical question remains: Are these tools actually effective? Let's unpack what's really going on. Generative AI: Potential Meets Practicality Generative AI (GenAI) uses machine learning to create content—emails, presentations, code and more. It's evolving fast and can solve real business problems—if it's trained on the right data. And that's the catch: Data is everything. Without high-quality, relevant data, even the most advanced AI is like bamboo: hollow and fragile. Why Customization Matters In Sales AI This is especially true for AI-driven sales productivity tools. Off-the-shelf models often fall short because they aren't tailored to your organization's unique sales processes, methodologies and buyer journeys. To be truly effective, AI must be trained and fine-tuned to reflect your workflows. The best tools don't just plug in; they adapt. They learn your language, your cadence and your customer behavior. That level of customization is what separates impactful AI solutions from generic ones. 'We Have AI, Too!' Today, nearly every vendor in CRM, sales performance management and conversation intelligence claims to use AI. It's become a standard part of the pitch: 'AI-driven platform.' Take conversation intelligence, for example. Many tools record customer calls and generate transcripts. But here's the truth: Volume alone doesn't equal value. Just having a massive archive of call recordings and transcripts isn't enough. The old saying 'garbage in, garbage out' still holds. Without meaningful analysis, these tools risk becoming little more than a graveyard of conversations. The real value lies in extracting predictive insights and delivering actionable recommendations that improve sales outcomes. What Makes A Good Sales GenAI Tool? A successful GenAI tool must be deeply trained on your unique sales process, value propositions, product positioning, sales methodologies, buyer's journey and GTM strategies for each product line. The AI algorithms need to be trained on the right data to generate valuable insights and actionable outcomes. It's not just about data volume—it's about data quality. And here's the point: Not all sales GenAI tools are created equal. Slapping an 'AI' label on your tech stack won't fix a broken sales process. There's no magic switch. Before deploying any GenAI tool, it's essential to reassess and streamline your sales process. AI can enhance what already works, but it can't fix what's fundamentally flawed. Human Insight Still Matters AI doesn't replace the need for human input. We still need people to define the sales process, configure business requirements and articulate desired outcomes. Simply feeding a list of discovery call questions won't cut it. Why? Because every sales conversation is unique. It evolves based on the customer's responses, needs and goals. Generic tools with rigid templates often fall short, producing mountains of transcripts but offering little insight. Many sales enablement and operations teams are learning this the hard way: Without flexibility and deep customization, AI tools become just another source of noise. What To Look For In A Sales GenAI Tool Having worked extensively with GenAI-powered sales productivity tools, I've seen how transformative they can be when implemented thoughtfully. I have noticed huge improvements in how reps are doing better discovery and driving more revenue. The right tool can significantly boost sales productivity. Our team, for instance, has uncovered deeper customer needs during discovery calls, thanks to AI-driven guidance. Predictive analytics has enhanced our visibility into early-stage deals, helping us prioritize and forecast more effectively. But the benefits go further. A well-designed Sales GenAI tool should: • Surface customer sentiment and disposition trends. • Identify recurring objections and competitive mentions. • Provide actionable insights, not just data dumps. If you're exploring GenAI tools to boost sales productivity with real insights and actionable predictions, it's important to look beyond the buzzwords. Consider these five key factors: • Goal Alignment: Not all GenAI tools are created equal. Choose a solution that aligns with your specific goals, whether that's improving discovery calls, forecasting deals or surfacing customer insights. • Customization: One-size-fits-all rarely works. While some vendors offer templates for popular sales methodologies like MEDDIC, these can be too generic. Look for a tool that adapts to your unique sales processes, not one that forces you to adapt to its limitations. • Cost: Customization often comes at a price. Understand the full scope of investment, including professional services and deployment costs investment before committing. • Deeper Insights: Recording calls and generating transcripts is table stakes. The real value lies in the insights. Choose a tool that goes beyond surface-level data to deliver actionable intelligence, not just a searchable archive of conversations. • Collaboration: Successful implementation requires cross-functional collaboration. Engage key stakeholders—SalesOps, sales leadership, enablement, demand gen and marketing—from the start. Their input is critical in defining business requirements, validating the tool's effectiveness and ensuring long-term success. Final Thoughts AI-powered sales productivity tools can transform how your organization sells, but only if they're aligned with your unique needs and goals. There's no universal solution, no magic metric that guarantees success. The real value lies in selecting the right tool and tailoring it to your business. Some GenAI tools deliver measurable impact, others fall short. The difference? It's both science and art. Science is in the strength of the GenAI engine. Art is in how well it's customized to reflect your sales processes, customer journey and organizational priorities. This isn't just a tech decision, it's a strategic one. Take the time to evaluate, involve the right stakeholders and plan for long-term success. With thoughtful implementation, the right GenAI tool can unlock insights, drive efficiency and elevate your sales performance. The journey starts now. Are you ready to lead it? Forbes Business Development Council is an invitation-only community for sales and biz dev executives. Do I qualify?

Andy Jassy says AI will eliminate some Amazon jobs — but create more in at least 2 areas
Andy Jassy says AI will eliminate some Amazon jobs — but create more in at least 2 areas

Yahoo

time4 hours ago

  • Yahoo

Andy Jassy says AI will eliminate some Amazon jobs — but create more in at least 2 areas

Amazon's CEO, Andy Jassy, says AI will transform jobs at the company. The tech will create new jobs in robotics and AI, despite automating some existing roles, he said. Amazon has 500 open robotics roles on LinkedIn. AI isn't all doom and gloom for jobs, said Amazon's Andy Jassy. In an interview with CNBC published on Monday, the Amazon CEO deemed AI "the most transformative technology in our lifetime." He said that it would change things not only for Amazon customers but also for its employees. Jassy said that AI technologies would create jobs in at least two areas of the company. "With every technical transformation, there will be fewer people doing some of the jobs that the technology actually starts to automate," he said. "Are there going to be other jobs? We're going to hire more people in AI and more people in robotics, and there are going to be other jobs that the technology wants you to go higher that we'll hire over time too." Jassy said that AI agents, which do tasks like coding, research, analytics, and spreadsheet work, would also change the nature of every employee's job. "They won't have to do as much rote work," he said. "Every single person gets to start every task at a more advanced starting spot." On LinkedIn, Amazon has added at least 500 open roles worldwide with the keyword "robotics" in the job title in the past month. Roles span internships to senior applied scientist positions. The Amazon robotics senior applied scientist job description includes tasks like "developing machine-learning capabilities and infrastructure for robotic perception and motion" and "building visualization tools for analyzing and debugging robot behavior." Jassy's comments came in response to a question about his June 17 memo, which outlined how AI would change the company's workforce. "It's hard to know exactly where this nets out over time, but in the next few years, we expect that this will reduce our total corporate workforce as we get efficiency gains from using AI extensively across the company," he wrote. Some Amazon employees were not happy with Jassy's message. In internal Slack channels, some called for leadership to share in the fallout, while others saw it as a layoff warning, Business Insider reported. "There is nothing more motivating on a Tuesday than reading that your job will be replaced by AI in a few years," one person wrote in Slack. Amazon employs about 1.5 million workers, according to its website, and has cut almost 28,000 jobs since the start of 2022, per From Jassy's memo and Monday's interview, it is unclear which or how many Amazon employees would be affected by AI-driven job changes. Other tech CEOs have raised the alarm on AI-related job cuts, especially for white-collar and entry-level roles. In April, Micha Kaufman, the CEO and founder of the freelance-job site Fiverr, wrote in an email to employees that: "It does not matter if you are a programmer, designer, project manager, data scientist, lawyer, customer support rep, salesperson, or a finance person — AI is coming for you." In late May, Anthropic's CEO, Dario Amodei, suggested AI could wipe out half of all entry-level white-collar jobs. "We, as the producers of this technology, have a duty and an obligation to be honest about what is coming," Amodei told Axios in an interview. "I don't think this is on people's radar." Read the original article on Business Insider

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store